World’s First Clinical Trial for anti-Abeta Vaccine Targeting Alzheimer’s Disease-like Characteristics in People with Down Syndrome

Categories: Blog, Clinical Trials, Ds / Alzheimer's Connection, Ds Research, News
PRESS RELEASE – Issued by AC Immune Studies AC Immune’s ACI-24, the first anti-amyloid vaccine for treatment of Alzheimer’s disease-like characteristics in people with Down syndrome Clinical Study is done in collaboration with University of California San Diego US NIH provides significant funding with an additional grant from the LuMind Research Down Syndrome Foundation Alzheimer’s …

Read More

In Memoriam: Dr. Pavel Belichenko

Categories: Blog

It is with great  sadness that we share that Dr. Pavel Belichenko passed away unexpectedly on August 9, 2014. Pavel has been a key member of the research group working together with Bill Mobley and supported by the LuMind Foundation since 2004, both at Stanford and more recently at University of California, San Diego. During …

Read More

UCSD Study Unraveling the Complexities between Down Syndrome and Alzheimer’s Disease

Categories: Blog, Ds / Alzheimer's Connection

Our friends at University of California, San Diego are helping to unravel the complexities of Down syndrome and Alzheimer’s disease. A news report from WFMZ in San Diego refers to a three-year pilot project involving a relatively small set of individuals with Down syndrome, like the impressive Jonathan Shirley. Dr. Mike Rafii, the principal investigator on …

Read More